BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11589933)

  • 21. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
    J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS; Bagheri S; Nichols K;
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy.
    Weinstock MA; Coulter S; Bates J; Bogaars HA; Larson PL; Burmer GC
    Arch Dermatol; 1995 Jun; 131(6):701-4. PubMed ID: 7778923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
    Stern RS; Lunder EJ
    Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of ciclosporin in psoriasis: a clinical review.
    Ho VC
    Br J Dermatol; 2004 May; 150 Suppl 67():1-10. PubMed ID: 15115440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Puva therapy and carcinogenesis].
    Thomas P; Pannequin C
    Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
    [No Abstract]   [Full Text] [Related]  

  • 31. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
    Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
    Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple eruptive squamous cell carcinoma in a patient with chronic plaque psoriasis on adalimumab.
    Simpkin S; Oakley A
    Australas J Dermatol; 2013 Feb; 54(1):55-8. PubMed ID: 22758905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis, its treatment, and cancer in a cohort of Finnish patients.
    Hannuksela-Svahn A; Pukkala E; Läärä E; Poikolainen K; Karvonen J
    J Invest Dermatol; 2000 Mar; 114(3):587-90. PubMed ID: 10692122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
    Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple eruptive actinic keratoses and squamous cell carcinomata following PUVA therapy of more than 11 years.
    Beiteke U; Budde J; Lentner A; Stary A; Tronnier H
    Photodermatol; 1988 Dec; 5(6):274-6. PubMed ID: 3249686
    [No Abstract]   [Full Text] [Related]  

  • 37. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
    Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
    Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.
    Stern RS
    N Engl J Med; 1990 Apr; 322(16):1093-7. PubMed ID: 2320078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoma risk in psoriasis: results of the PUVA follow-up study.
    Stern RS
    Arch Dermatol; 2006 Sep; 142(9):1132-5. PubMed ID: 16983000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A.
    Wolf P; Seidl H; Bäck B; Binder B; Höfler G; Quehenberger F; Hoffmann C; Kerl H; Stark S; Pfister HJ; Fuchs PG
    Arch Dermatol; 2004 Mar; 140(3):317-24. PubMed ID: 15023775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.